STKH pivots to licensing 3D bioprinting hardware and bio-inks to food manufacturers, reducing capital expenditure and extending cash runway.
Steakholder Foods Ltd. (NASDAQ:STKH) has transitioned to a business-to-business model, licensing its 3D bioprinting technology and bio-inks to global food manufacturers. This shift aims to reduce the company’s capital expenditure by avoiding in-house meat production.
The company specializes in proprietary bioprinting hardware designed to replicate the texture and structure of whole-muscle cuts like beef steaks. By focusing on B2B licensing, STKH positions itself as a key infrastructure provider for the alternative protein sector, targeting high-margin, recurring revenue streams.
This strategic pivot follows the broader industry trend of asset-light models, which lower operational risks and extend financial runways. The move is expected to attract partnerships with major food processors and alternative protein brands.